SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.32+1.4%3:26 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (16801)4/18/2004 12:50:32 PM
From: Bluegreen   of 17367
 
Hey George, wouldn't Raptiva have to be tested in large scale trials against current therapies in Europe in order to be approved there??? If NOT approved in Europe can you see a flush out to the 2 area in stock price?? I sure don't see SCANNON buying at these prices. Is he waiting for a much LOWER stock price???? You know he is the one who FOUNDED the company. Does he have DISDAIN for the company itself or just the stock price???? Look at the salary the guy gets and HUGE profit he just made on flipping those options. Couldn't he take around 225,000
dollars and buy 50,000 shares on the open market???
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext